Influence of Antipsychotics on Functional Prognosis After Geriatric Hip Fracture
To investigated the effects of antipsychotics on rehabilitation outcomes for geriatric hip fracture inpatients.
Retrospective cohort study.
The registry data from the Japan Rehabilitation Nutrition Database for analysis.
Of the 234 patients in the Japan Rehabilitation Nutrition Database admitted between November 2015 and March 2018, 214 met the eligibility criteria.
The antipsychotics were phenothiazine, butyrophenone, benzamide, and atypical antipsychotics. For hip fracture patients, the following information was registered: (a) admission data: age, sex, Charlson Comorbidity Index, Functional Independence Measure (FIM) at admission, medications, height, body weight, and Mini Nutritional Assessment-Short Form score (MNA-SF) and (b) discharge data: discharge destination, FIM at discharge, MNASF, and total units of provided rehabilitation therapy (one unit = 20 minutes based on the national healthcare insurance policy).
Thirteen patients (6.1%) were prescribed antipsychotics. According to the multiple linear regression analysis, antipsychotics negatively affected FIM efficiency (β=-0.190, 95% confidence interval, -0.652 to -0.104, p=0.007). Furthermore, on logistic regression analysis, fall during hospitalization was correlated with the use of antipsychotics (odds ratio=4.376, 95% confidence interval: 1.153 to 16.612, p=0.030).
The use of antipsychotics impaired the improvement of the activities of daily living (ADL) and increased the incidence of fall during hospitalization. Reviewing medication therapies at admission may further improve ADL.
Key wordsActivities of daily living antipsychotics fall geriatric hip fracture
- 6.Lai, SW, Liao, KF, Liao, CC, Muo, CH, Liu, CS, Sung, FC. Polypharmacy correlates with increased risk for hip fracture in the elderly: a population-based study. Medicine(Baltimore) 2010;89:295–299. doi: 10.1097/MD.0b013e3181f15efcGoogle Scholar
- 12.Nagano, A, Nishioka, S, Wakabayashi, H. Rehabilitation nutrition for iatrogenic sarcopenia and sarcopenic dysphagia. J Nutr Health Aging, 2018. doi: https://doi. org/10.1007/s12603-018-1150-1Google Scholar
- 15.Kose, E, Maruyama, R, Okazoe, S, Hayashi, H. Impact of polypharmacy on the rehabilitation outcome of Japanese stroke patients in the convalescent rehabilitation ward. J Aging Res 2016. doi: 10.1155/2016/7957825Google Scholar
- 17.Kose, E, Hirai, T, Seki, T. Psychotropic drug use and cognitive rehabilitation practice for elderly patients. Int J Clin Pharm 2018. doi: 10.1007/s11096-018-0718-5.Google Scholar
- 25.Kojima, T, Mizukami, K, Tomita, N, Arai, H, Ohrui, T, Eto, M, Takeya, Y, Isaka, Y, Rakugi, H, Sudo, N, Arai, H, Aoki, H, Horie, S, Ishii, S, Iwasaki, K, Takayama, S, Suzuki, Y, Matsui, T, Mizokami, F, Furuta, K, Toba, K, Akishita, M. Screening Tool for Older Persons’ Appropriate Prescriptions in Japanese: Report of the Japan Geriatrics Society Working Group on “Guidelines for medical treatment and its safety in the elderly.” Geriatr Gerontol Int 2016;16:983–1001. doi: 10.1111/ggi.12890CrossRefGoogle Scholar
- 26.Lee, SJ, Newman, TB, Avorn, J, Fischer, MA, Mogun, H, Solomon, DH, Brookhart, MA. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med 2005;353:2335–2341. doi: 10.1056/NEJMoa052827Google Scholar
- 28.Mauri, MC, Volonteri, LS, Colasanti, A, Fiorentini, A, De Gaspari, IF, Bareggi, SR. Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response. Clin Pharmacokinet 2007;46:359–388. doi: 10.2165/00003088-200746050-00001CrossRefGoogle Scholar
- 29.Lövheim, H, Sandman, PO, Kallin, K, Karlsson, S, Gustafson, Y. Relationship between antipsychotic drug use and behavioral and psychological symptoms of dementia in old people with cognitive impairment living in geriatric care. Int Psychogeriatrics 2006;18:713–726. doi: 10.1017/S1041610206003930CrossRefGoogle Scholar